CRISPR Therapeutics AG (CRSP) concluded the recent trading session at $54.21, signifying a -4.71% move from its prior day's close.

Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...

The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.Elevate your expertise in molecular ...

Intellia Therapeutics CEO John Leonard explained the circumstances of the patient death at the JP Morgan Healthcare ...

Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...

Science Unlocks the , Vitamin D Potential of Tomatoes. CNN reports vitamin D, a necessary nutrient, is often hard to find ...

Researchers explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.

To combat this problem, scientists have been attempting to use genetic engineering to help crops control their own ...